Literature DB >> 17490639

Diabetes-induced alterations of adenosine receptors expression level in rat liver.

Marzena Grden1, Marzena Podgorska, Andrzej Szutowicz, Tadeusz Pawelczyk.   

Abstract

Diabetes mellitus is associated with metabolic, functional, and structural changes in the liver. Adenosine has been demonstrated to play an important regulatory role in the liver, and its action has been associated with all four adenosine receptors (ARs) subtypes. The goal of this study was to evaluate the impact of streptozotocin-induced diabetes on expression level of ARs in rat liver. Performed analyses (real-time PCR, Western blots) revealed detectable levels of mRNA and protein of A(1)-AR, A(2A)-AR, A(2B)-AR, and A(3)-AR in the rat liver. Development of diabetes resulted in a significant increase of A(2A)-AR and A(3)-AR mRNA levels. This was associated with elevated ARs protein content. The level of A(2B)-AR mRNA in diabetic liver decreased approximately 40% and was accompanied by 60% drop in A(2B)-AR protein in liver membranes. Diabetes did not affect the expression level of A(1)-AR in the liver. Administration of insulin for four days to diabetic rats resulted in returning of the ARs expression to the levels observed in liver of normal rat. The changes in ARs genes expression and receptors protein content could be related to some pathological changes taking place in diabetic liver. This might suggest involvement of ARs in pathogenesis of liver disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490639     DOI: 10.1016/j.yexmp.2007.03.005

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  12 in total

Review 1.  Adenosine receptor agonists for promotion of dermal wound healing.

Authors:  María D Valls; Bruce N Cronstein; M Carmen Montesinos
Journal:  Biochem Pharmacol       Date:  2008-11-12       Impact factor: 5.858

Review 2.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

3.  Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; S Jamal Mustafa
Journal:  Eur J Pharmacol       Date:  2017-12-18       Impact factor: 4.432

Review 4.  Purinergic Signaling in Liver Pathophysiology.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-11       Impact factor: 5.555

5.  Adenosine A1 receptor is dispensable for hepatocyte glucose metabolism and insulin sensitivity.

Authors:  Shanu Jain; Luiz F Barella; Jürgen Wess; Marc L Reitman; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2021-08-19       Impact factor: 6.100

6.  A₁ adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Authors:  Bunyen Teng; Jonathan D Smith; Michael E Rosenfeld; Peggy Robinet; Mary E Davis; R Ray Morrison; S Jamal Mustafa
Journal:  Cardiovasc Res       Date:  2014-02-12       Impact factor: 10.787

7.  Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; Zhichao Zhou; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2015-12-02       Impact factor: 5.000

8.  A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity.

Authors:  Balázs Csóka; Gábor Törő; Joana Vindeirinho; Zoltán V Varga; Balázs Koscsó; Zoltán H Németh; Endre Kókai; Luca Antonioli; Mara Suleiman; Piero Marchetti; Karolina Cseri; Ádám Deák; László Virág; Pál Pacher; Péter Bai; György Haskó
Journal:  FASEB J       Date:  2017-08-01       Impact factor: 5.191

Review 9.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

10.  Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome.

Authors:  Shawn B Bender; Johnathan D Tune; Lena Borbouse; Xin Long; Michael Sturek; M Harold Laughlin
Journal:  Exp Biol Med (Maywood)       Date:  2009-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.